Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study-Reference-Cited by-同舟云学术

Daily dose of interferon alpha-2b and ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection: a randomised controlled study

Published:2006-07 Issue:2 Volume:1 Page:113-118
ISSN:1828-0447
Container-title:Internal and Emergency Medicine
language:en
Short-container-title:Int Emergency Med

Author:

Benetti GianPiero,Borzio Mauro,Ramella Giuliano,Bellati Giorgio,Fargion Silvia,Colombo Alberto,Croce Guido,Iamoletti Carlo,Balzola Federico,Rizzetto Mario,

Publisher

Springer Science and Business Media LLC

Subject

Emergency Medicine,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF02936535.pdf

Reference18 articles.

1. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C.Hepatology 1997; 26 (Suppl 1): 2S–10S.

2. Davis GL. Monitoring of viral levels during therapy of hepatitis C.Hepatology 2002; 36 (Suppl 1): S145-S151.

3. Cawthorne CH, Rudat KR, Burton MS, et al. Limited success of HCV antiviral therapy in United States veterans.Am J Gastroenterol 2002; 97:149–55.

4. Falck-Ytter Y, Kale H, Mullen KD, Sarbah SA, Sorescu L, McCullough AJ. Surprisingly small effect of antiviral treatment in patients with hepatitis C.Ann Intern Med 2002; 136:288–92.

5. Zeuzem S, Lee JH, Franke A, et al. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.Hepatology 1998;27:1149–56.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The faster the better?;Internal and Emergency Medicine;2006-07